NaviGate Cardiac Structures, Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From NaviGate Cardiac Structures, Inc.
For patients with severe or irreversible moderate mitral regurgitation, NaviGate Cardiac Structures Inc. is developing a catheter-guided compressible valved stent that fits within the diseased mitral valve in a beating heart.
In this month's issue of Start-Up, we profile Alcresta Pharmaceuticals, Gordian Surgical, International Biomedical Devices, NaviGate Cardiac Structures, ObsEva and SweetBio.
Case Study: Cross-Strait Agreement Could Shorten IND Timeframe For Products Entering China (Part 2 of 2)
Global pharmaceutical firms can look no further than across the Taiwan Strait when working to get products approved and launched in China faster.
The Melbourne biotech firm Cytopia is challenging a merger between the Australian biotechs Progen Pharmaceuticals and Avexa, saying it can offer a better deal to Progen shareholders.
- Medical Devices
- Other Names / Subsidiaries
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.